Beijing Medical and Health Industry Investment Fund
北京市医药健康产业投资基金
Beijing Medical and Health Industry Investment FundFund
北京市医药健康产业投资基金
渲染中…
Mentioned in 3 articles
Coverage
3D Cell Manufacturing Platform Huaxin Biotech Closes Series B+ Round to Accelerate Cell Therapy Commercialization for Global Clients
Ushering in the 2.0 era of cell-based industrialization.
高榕创投·Gaorong Report · 2025 | Innovative Drugs, Agri-Tech, AI Content Platforms Close Funding Rounds; Gaorong Earns Multiple Accolades
Innovation as the sail, hard work as the oar.
高榕创投·Qihe Biotech Closes Over RMB 200 Million Series A to Accelerate Gene Editing R&D and Commercialization
Develop novel gene-editing technologies to create exceptional biological traits and products.
高榕创投·
